DarrenRossGitelmanMDFAAN, FANA
Neurology • Park Ridge, ILNeurodegenerative, Dementia & Geriatrics
Senior Medical Director, Advocate Memory Center, Professor of Medicine - Rosalind Franklin University of Medicine and Science, Adjunct Associate Professor of Neurology and Radiology - Ken and Ruth Davee Department of Neurology, Northwestern University
Dr. Gitelman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1875 Dempster St.
Suite 520
Park Ridge, IL 60068Phone+1 847-720-6464Fax+1 847-720-6463- Is this information wrong?
Education & Training
Beth Israel Deaconess Medical Center1992 - 1994
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1989 - 1992
NewYork-Presbyterian/Columbia University Irving Medical Center1988 - 1989
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1986 - 1988- New York Presbyterian Hospital (Columbia Campus)Internship, Internal Medicine, 1985 - 1986
Washington University in St. Louis School of MedicineClass of 1985
Certifications & Licensure
IL State Medical License 1994 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Psychiatry and Neurology Neurology
- United Council for Neurologic SubspecialtiesBehavioral Neurology & Neuropsychiatry
Awards, Honors, & Recognition
- Top Doctor Chicago Magazine, 2020-2024
- Top Doctor Castle Connolly, 2015-2024
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease Start of enrollment: 2008 Dec 19
- PharmacoMRI of Parkinson Disease Start of enrollment: 2011 Jun 01
- Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001 Start of enrollment: 2012 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsStudy design and methods: U.S. study to protect brain health through lifestyle intervention to reduce risk (U.S. POINTER).Laura D Baker, Heather M Snyder, Mark A Espeland, Rachel A Whitmer, Miia Kivipelto, Nancy Woolard, Jeffrey Katula, Kathryn V Papp, Jennifer Ventrelle, Sarah Graef, Mar...> ;Alzheimer's & Dementia. 2024 Feb 1
- 2 citationsOptimizing quantification of MK6240 tau PET in unimpaired older adults.Theresa M Harrison, Tyler J Ward, Alice Murphy, Suzanne L Baker, Pablo A Dominguez, Robert Koeppe, Prashanthi Vemuri, Samuel N Lockhart, Youngkyoo Jung, Danielle J Har...> ;Neuroimage. 2023 Jan 1
- 5 citationsCognitive Impairment in Aging Physicians: Current Challenges and Possible Solutions.Gayatri Devi, Darren R. Gitelman, Daniel Z. Press, Kirk R. Daffner> ;Neurology. Clinical Practice. 2021 Apr 1
- Join now to see all
Journal Articles
- Cognitive impairment in aging physiciansG Devi, DR Gitelman, D Press, K Daffner, Neurology: Clinical Practice, 3/13/2020
Press Mentions
‘The Hemsworth Alzheimer’s Disease Gene’: Revisiting the Nature-Nurture DebateJanuary 17th, 2023- An Alzheimer’s Treatment Receives Accelerated ApprovalJanuary 12th, 2023
- Weight Training Isn't Such a Heavy Lift. Here Are 7 Reasons Why You Should Try ItSeptember 26th, 2021
- Join now to see all
Grant Support
- Education, digital tools, and diagnostic support to increase PCP-based cognitive testing in patients 65 years and olderDavos Alzheimer's Collaborative2022–2023
- The Parkinson’s Progression Markers Initiative (PPMI) – T1 Standardization Sub-StudyMichael J Fox Foundation2014–2016
- The Parkinson’s Progression Markers Initiative (PPMI) – rsMRI Sub-StudyMichael J Fox Foundation2012–2016
- A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Effectiveness of Immune Globulin Intravenous (Human), 10% Solution (IGIV, 10%) for the Treatment of Mild to Moderate Alzheimer's Disease (ADBaxter Healthcare Corporation2012–2013
- PharmacoMRI of Parkinson’s disease: A Pilot Study of Drug Effects on ConnectivityPaul Ruby Foundation2011–2012
- High Resolution Diffusion tensor MRI Imaging as a Biomarker of Parkinson’s Disease Diagnosis and Disease ProgressionMichael J Fox Foundation2009–2012
- Structural And Functional Mapping Of Progressive AphasiaNational Center For Research Resources2004–2009
- Neural Network Stability And Variability In Normal AgingNational Institute On Aging1999–2003
Committees
- Chair, United Council for Neurologic Subspecialties Certification Council 2020 - 2023
Professional Memberships
- American Neurological AssociationFellow
- International Society to Advance Alzheimer's Research and TreatmentMember
- Fellow
- International Society for Frontotemporal DementiaMember
Hospital Affiliations
Advocate Lutheran General HospitalPark Ridge, Illinois
External Links
- Advocate Memory Centerhttp://www.advocatehealth.com/memorycenter
- AMG Doctorshttp://doctors.advocatehealth.com/a/darren-r-gitelman-park-ridge-neurology
- Northwestern Universityhttp://www.neurology.northwestern.edu/faculty/profile.html?xid=14246
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
